1. Home
  2. DCI vs ALKS Comparison

DCI vs ALKS Comparison

Compare DCI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

SELL

Current Price

$86.44

Market Cap

10.3B

Sector

Industrials

ML Signal

SELL

Logo Alkermes plc

ALKS

Alkermes plc

SELL

Current Price

$40.21

Market Cap

8.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DCI
ALKS
Founded
1915
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
8.7B
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
DCI
ALKS
Price
$86.44
$40.21
Analyst Decision
Hold
Buy
Analyst Count
8
19
Target Price
★ $100.40
$56.28
AVG Volume (30 Days)
577.0K
★ 2.3M
Earning Date
12-03-2026
10-27-2026
Dividend Yield
★ 1.47%
N/A
EPS Growth
★ 26.23
N/A
EPS
★ 3.85
N/A
Revenue
★ $2,844,900,000.00
$1,475,899,000.00
Revenue This Year
$7.86
$23.54
Revenue Next Year
$4.88
$6.53
P/E Ratio
$22.66
★ N/A
Revenue Growth
★ 4.05
N/A
52 Week Low
$79.61
$27.00
52 Week High
$112.84
$55.67

Technical Indicators

Market Signals
Indicator
DCI
ALKS
Relative Strength Index (RSI) 41.21 37.87
Support Level $85.82 $39.84
Resistance Level $87.80 $43.22
Average True Range (ATR) 1.53 1.11
MACD 0.07 0.05
Stochastic Oscillator 13.16 25.71

Price Performance

Historical Comparison
DCI
ALKS

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts, including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors. The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.9 billion in revenue in its fiscal year 2026.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: